AULOS BIOSCIENCE DOSES FIRST PATIENT IN PHASE 2 COHORT EVALUATING AU-007 IN COMBINATION WITH NIVOLUMAB FOR SECOND-LINE TREATMENT OF MELANOMA

Reuters · 4d ago

Please log in to view news